RESUMO
BACKGROUND: Recently, we have shown that mast cell mitochondrial STAT3 could serve as a new target for the regulation of the allergic response as it plays an essential role in immunologically mediated degranulation of mast cells. In the present work, we explored how two recently developed mitochondrial STAT3 inhibitors (Mitocur-1 and Mitocur-3) modulate the allergic response. METHODS: Experiments were performed both in vitro in cultured human/mouse mast cells and with rat basophilic leukemia (RBL) cells and also in vivo in mice. The effect of mitochondrial STAT3 inhibition on mast cell function was determined via checking degranulation and several cytokines secretion levels. RESULTS: Here, we show that treatment of rodent and human cultured mast cells with low concentrations of mitochondrial STAT3 inhibitors had no effect on STAT3 target gene expression. However, these inhibitors caused a significant reduction in mast cell exocytosis and cytokine release, due to a decrease in OXPHOS activity and STAT3 serine 727 phosphorylation. It was also observed in an OVA mouse model of allergic asthma that one of the inhibitors used significantly reduced eosinophilia and neutrophilia compared to the control mice group. Furthermore, it was observed that treatment with this inhibitor resulted in a significant reduction in blood histamine levels in mice after IgE-Ag challenge. CONCLUSION: The present data strongly suggest that the development of mitochondrial STAT3 inhibitors could serve as a potential treatment for allergy-associated diseases.
Assuntos
Antialérgicos/farmacologia , Hipersensibilidade/metabolismo , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/metabolismo , Fator de Transcrição STAT3/antagonistas & inibidores , Trifosfato de Adenosina/metabolismo , Animais , Antígenos/imunologia , Asma/tratamento farmacológico , Asma/genética , Asma/imunologia , Asma/metabolismo , Biomarcadores , Caspase 3 , Linhagem Celular , Feminino , Histamina/sangue , Humanos , Hipersensibilidade/tratamento farmacológico , Hipersensibilidade/genética , Hipersensibilidade/imunologia , Imunoglobulina E/sangue , Imunoglobulina E/imunologia , Masculino , Mastócitos/efeitos dos fármacos , Mastócitos/imunologia , Mastócitos/metabolismo , Camundongos , Consumo de OxigênioRESUMO
Mouse bone marrow-derived mast cells differentiated in vitro and sensitized with monoclonal IgE respond to antigen-initiated activation with the release of histamine, beta-hexosaminidase, chondroitin sulfate E proteoglycan, and leukotriene C4 (LTC4). The chondroitin sulfate E nature of the glycosaminoglycan side chain was established by demonstrating that the chondroitinase ABC disaccharide digestion products were composed of equal quantities of 4-sulfated and 4,6-disulfated N-acetyl-galactosamine. The single immunoreactive sulfidopeptide leukotriene, released and quantitated with a class-specific antibody, was identified as LTC4 by its retention time on reverse-phase high-performance liquid chromatography and by its specific spasmogenic activity on the guinea pig ileum. The release of the preformed mediators, as well as of LTC4, was related in a dose-response fashion to the concentration of monoclonal IgE used during the sensitization step and to the concentration of specific antigen used to initiate the activation-secretion response. The optimal concentrations of IgE for sensitization and of antigen for challenge were the same for the release of preformed mediators and of LTC4. In addition, the time courses of their release were superimposable, with a plateau at 5 min after antigen challenge. The release of three preformed mediators and of LTC4 after fixation of IgE, washing of the sensitized cells, and antigen challenge unequivocally indicates a bone marrow-derived mast cell origin for these products. Linear regression analyses of the net percent release of beta-hexosaminidase to histamine and of 35S-chondroitin sulfate E to beta-hexosaminidase yielded straight lines that intersected at the origin, which indicates that the three preformed mediators are localized in the secretory granules of the bone marrow-derived mast cells. The concomitant generation of 23 ng of LTC4/10(6) sensitized bone marrow-derived mast cells represents the first example of IgE-dependent release of substantial amounts of LTC4, a component of slow reacting substance of anaphylaxis, from a mast cell population of greater than 95% purity. The IgE-dependent generation of LTC4, rather than prostaglandin D2, by the chondroitin sulfate E proteoglycan-containing bone marrow-derived mast cells contrasts with the predominant generation of prostaglandin D2 by heparin proteoglycan-containing mast cells. These differences together support the existence of two phenotypically different mast cell subclasses.
Assuntos
Hexosaminidases/metabolismo , Liberação de Histamina , Imunoglobulina E/imunologia , Mastócitos/imunologia , Proteoglicanas/metabolismo , SRS-A/metabolismo , Animais , Células da Medula Óssea , Células Cultivadas , Sulfatos de Condroitina/metabolismo , Exocitose , Mastócitos/metabolismo , CamundongosRESUMO
Microphthalmia transcription factor (MITF) is a basic helix-loop-helix leucine zipper (bHLH-Zip) DNA-binding protein. This transcription factor plays a crucial role in the physiological and pathological functions of distinct cell types. MITF transcriptional activity is inhibited by the histidine triad nucleotide-binding protein 1 (HINT1) through direct binding. We previously reported that this association is disrupted by the binding of the second messenger Ap4A to HINT1. Ap4A is mainly produced in the mammalian cells by S207-phosphorylated Lysyl-tRNA synthetase. In this study, we found first that HINT1 was subjected to K21 acetylation and Y109 phosphorylation in activated mast cells, together with the Ap4A-triggered HINT1 dissociation from MITF. Mutational analysis confirmed that these modifications promote MITF transcriptional and oncogenic activity in melanoma cell lines, derived from human melanoma patients. Thus, we provided here an example that manipulation of the LysRS-Ap4A-HINT1-MITF signalling pathway in melanoma through post-translational modifications of HINT1 can affect the activity of the melanoma oncogene MITF.
Assuntos
Proteínas de Transporte/metabolismo , Proteínas de Ligação a DNA/metabolismo , Melanoma/metabolismo , Fator de Transcrição Associado à Microftalmia/metabolismo , Proteínas do Tecido Nervoso/metabolismo , Processamento de Proteína Pós-Traducional , Neoplasias Cutâneas/metabolismo , Ativação Transcricional , Acetilação , Proteínas Adaptadoras de Transdução de Sinal/genética , Proteínas Adaptadoras de Transdução de Sinal/metabolismo , Linhagem Celular Tumoral , Quinase 2 Dependente de Ciclina/genética , Quinase 2 Dependente de Ciclina/metabolismo , Análise Mutacional de DNA , Humanos , Mastócitos/metabolismo , Melanoma/genética , Proteínas de Membrana/genética , Proteínas de Membrana/metabolismo , Fator de Transcrição Associado à Microftalmia/genética , Proteínas do Tecido Nervoso/genética , Fosforilação , Ligação Proteica , Transdução de Sinais , Neoplasias Cutâneas/genéticaRESUMO
Upstream stimulating factor (USF2) is a basic helix-loop-helix leucine zipper transcription factor, which is found in most tissues. A critical role for USF2 in cellular proliferation has been proposed based on its importance in the regulation of various cyclins and P53 and its capability to antagonize c-myc. In this paper we report that IL-3, which is a major growth factor for mast cells, induces USF2 protein synthesis in murine mast cells (MC-9). Surprisingly, it does not significantly affect the level of USF2 mRNA in these cells at any of the time points tested. Using polysomal fractionation and RNA analysis we then demonstrated that this translational regulation is mostly the result of increased USF2 translational efficiency. Moreover, protein kinase C (PKC) inhibitors prevented both the induction of USF2 protein synthesis and the increase in USF2 translational efficiency in IL-3-activated mast cells. Two other hematopoietic cell lines were used to determine whether the translational regulation of USF2 is of a more general nature: mouse lymphosarcoma cells whose proliferation is inhibited by dexamethasone; and mouse erythroleukemia cells that differentiate upon exposure to hexamethylen bisacetamide. In both cell types, USF2 translation was repressed in the non-dividing cells. This strongly implies that USF2 is translationally repressed in quiescent hematopoietic cells. Considering the proposed role of USF in proliferation it seems that translational regulation of USF2 might have an important role in cellular growth.
Assuntos
Proteínas de Ligação a DNA , Sequências Hélice-Alça-Hélice , Interleucina-3/metabolismo , Zíper de Leucina , Mastócitos/metabolismo , Biossíntese de Proteínas , Proteína Quinase C/metabolismo , RNA Mensageiro/biossíntese , Fatores de Transcrição/biossíntese , Animais , Divisão Celular , Linhagem Celular , Interleucina-3/farmacologia , Cinética , Mastócitos/citologia , Mastócitos/efeitos dos fármacos , Camundongos , Coelhos , Fatores de Transcrição/genética , Células Tumorais Cultivadas , Regulação para Cima , Fatores Estimuladores UpstreamRESUMO
The inhibitory effect of the drug BW755C on the 5-lipoxygenase pathway was analyzed for bone marrow-derived murine mast cells, termed E-mast cells. The drug prevented the formation of 5-HETE from exogenous [14C]arachidonic acid when IgE-sensitized cells were challenged by the antigen. BW755C also prevented formation of leukotriene C4 in a dose-dependent fashion when IgE-sensitized mast cells, preincubated with the drug, were activated with either the specific antigen or the ionophore. Leukotriene C4 inhibition occurred with a minimal drug preincubation period of 1 min before the cells were subjected to antigen-dependent activation. BW755C did not affect the degranulation response of these cells. Thus in an intact cell system BW755C prevents 5-lipoxygenation of arachidonic acid. Furthermore, this study reveals that even with transmembrane activation of E-mast cells through their IgE-Fc receptors, granule secretion is not dependent upon corresponding metabolites from the 5-lipoxygenase pathway.
Assuntos
Inibidores de Lipoxigenase , Mastócitos/enzimologia , Pirazóis/farmacologia , 4,5-Di-Hidro-1-(3-(Trifluormetil)Fenil)-1H-Pirazol-3-Amina , Animais , Células da Medula Óssea , Calcimicina/farmacologia , Grânulos Citoplasmáticos , Relação Dose-Resposta a Droga , Hexosaminidases/metabolismo , Liberação de Histamina , Ácidos Hidroxieicosatetraenoicos/biossíntese , Imunoglobulina E/imunologia , Masculino , Mastócitos/efeitos dos fármacos , Mastócitos/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , SRS-A/biossíntese , beta-N-Acetil-HexosaminidasesRESUMO
Mast cells were obtained from mouse bone marrow cells cultured for 14 days in medium derived from Concanavalin A (Con A) stimulated mouse spleen cells. Upon passive sensitization of the cultured cells with immunoglobulin E (IgE), histamine release from mast cells was approximately 200% above control within 1 min of incubation with anti-IgE. The calcium inonophore A 23187 also evoked a concentration-dependent (10(-8) M to 6 x 10(-7) M) histamine release following a 6 min incubation. Transmission electron microscopy (TEM) demonstrated that the secretory granules of the cultured cells have a peripheral crystalline pattern, like that previously demonstrated for mast cells. Scanning electron microscopy (SEM) illustrated spherical cells with surfaces traversed by many ridge-like folds. Intragranular fusion, following exposure of the IgE-bearing cells to anti-IgE, led to accumulation of the granules into channels which, on study with both transmission and scanning electron microscopy, appeared to be associated with the cell surface.
Assuntos
Células da Medula Óssea , Liberação de Histamina , Mastócitos/fisiologia , Animais , Calcimicina/farmacologia , Células Cultivadas , Concanavalina A/farmacologia , Meios de Cultura , Grânulos Citoplasmáticos/ultraestrutura , Exocitose , Liberação de Histamina/efeitos dos fármacos , Imunoglobulina E/imunologia , Técnicas In Vitro , Masculino , Mastócitos/ultraestrutura , Camundongos , Microscopia Eletrônica de VarreduraRESUMO
In the mouse hematopoietic system, 5-fluorouracil (5-FU) reversibly inhibits the generation of multilineage colonies containing granulocyte, erythroid, megakaryocyte, and macrophage lineage. To determine the effect of 5-FU on mastopoiesis in vitro, bone marrow cells were obtained from mice, cultured, and treated with 5-FU for 14 days in an interleukin-3 (IL-3)-enriched medium. A dose-related inhibitory effect of 5-FU on mastopoiesis was found. When an inhibitory dose (1 microgram/mL) of 5-FU was supplemented to the cultures for only 2, 4, or 8 days and the cells were then recultured without the drug, we observed inhibition of mastopoiesis directly related to the time of exposure of the cells to 5-FU. To determine the effect of 5-FU on mastopoiesis in vivo, bone marrow cells from mice that had received a single intravenous (i.v.) 5-FU injection (150 mg/kg) were cultured. A virtually total absence of mast cells was noted at days 1 and 2 following 5-FU administration. A gradual reappearance of mast cells was later observed. Whether mice were injected with the drug once or with four once-daily (100 mg/kg 5-FU) injections, a similar pattern of delay of mast cell appearance was observed. The findings suggest (1) an irreversible, nonadditive, toxic effect of 5-FU on mast cell precursors and (2) that most or all of the mast cell precursors are nonquiescent cells, continuously activated or cycling. In addition, the use of 5-FU may serve as a unique model system for controlling and studying mastopoiesis in normal mice, rather than the mutated mice currently studied.
Assuntos
Fluoruracila/farmacologia , Mastócitos/citologia , Animais , Diferenciação Celular/efeitos dos fármacos , Diferenciação Celular/fisiologia , Divisão Celular/efeitos dos fármacos , Divisão Celular/fisiologia , Células Cultivadas , Relação Dose-Resposta a Droga , Feminino , Fluoruracila/administração & dosagem , Hematopoese/efeitos dos fármacos , Hematopoese/fisiologia , Células-Tronco Hematopoéticas/citologia , Células-Tronco Hematopoéticas/fisiologia , Injeções Intravenosas , Interleucina-3/farmacologia , Mastócitos/fisiologia , Camundongos , Camundongos Endogâmicos C57BL , Fatores de TempoRESUMO
Stimulation of murine chondroitin sulfate E containing mast cells (E-MC) in vitro either by thrombin or immunologically resulted in a rapid formation of inositol phosphates (IPs). Increase in all of the three IPs (IP1, IP2 and IP3) could be detected 20 s after stimulation. The depletion of Ca2+ from the medium resulted in more than 80% reduction in beta-hexosaminidase release from either thrombin or IgE antigen stimulated cells. However, both thrombin and IgE antigen increased the formation of IP3 under these conditions independent of the presence of extracellular Ca2+.
Assuntos
Sulfatos de Condroitina/metabolismo , Condroitina/análogos & derivados , Imunoglobulina E/imunologia , Fosfatos de Inositol/metabolismo , Mastócitos/metabolismo , Fosfatos Açúcares/metabolismo , Trombina/farmacologia , Animais , Antígenos/imunologia , Cálcio/farmacologia , Células Cultivadas , Inositol/metabolismo , Lítio/farmacologia , Mastócitos/imunologia , CamundongosRESUMO
Mast cells can serve as a possible important source of cytokine production in inflamed tissue which can be regulated by stimuli different from those activating other immune system cells. To study the expression of specific genes in mast cells derived from small human colonic mucosal endoscopic biopsies, we first modified a previously reported procedure to achieve a significantly enriched mast cell fraction. Then, by using single-cell RT-PCR analysis the expression of the IgE Fc receptor (Fc epsilonRI) and c-kit mRNA was determined. It was observed that the Fc epsilonRI-positive cells also expressed c-kit. This observation provided further evidence that Fc epsilonRI-positive cells are indeed mast cells. Analysis of biopsies from 12 patients (four control and eight patients with inflammatory bowel disease (IBD)) was carried out, revealing that all of the Fc epsilonRI-positive cells expressed IL-3, while the expression of IL-4 was detected only in some of these positive cells. TNF alpha was not detected in these cells. Therefore, it would seem that most intestinal mast cells produce IL-3. Since it has been reported that IL-3 synthesis was down-regulated in steroid-treated cells, the expression pattern of IL-3 in intestinal mast cells derived from steroid-treated IBD patients was then determined. IL-3 mRNA was detected in only two out of 24 Fc epsilonRI-positive cells derived from these steroid-treated patients. These results lend strong support to the idea that the down-regulation of IL-3 in mast cells derived from steroid-treated IBD patients occurs in vivo and could be an important mechanism for immunomodulation in IBD.
Assuntos
Glucocorticoides/uso terapêutico , Doenças Inflamatórias Intestinais/imunologia , Interleucina-3/biossíntese , Interleucinas/biossíntese , Mucosa Intestinal/imunologia , Mastócitos/imunologia , Receptores de IgE/biossíntese , Transcrição Gênica/efeitos dos fármacos , Biópsia , Células Cultivadas , Colo/citologia , Colo/imunologia , Colo/patologia , Primers do DNA , Regulação da Expressão Gênica/efeitos dos fármacos , Humanos , Doenças Inflamatórias Intestinais/tratamento farmacológico , Doenças Inflamatórias Intestinais/patologia , Interleucina-4/biossíntese , Interleucina-8/biossíntese , Mucosa Intestinal/citologia , Mucosa Intestinal/patologia , Mastócitos/citologia , Mastócitos/patologia , Sondas de Oligonucleotídeos , Reação em Cadeia da Polimerase/métodos , Receptores de IgE/análise , Valores de ReferênciaRESUMO
Expression of catalytically active protein was detected in a murine mast cell line. The primary type of AChE mRNA produced by these cells was found to be the brain and muscle type by PCR amplification of alternative exons from the 3' of mast cells AChE cDNA. AChE was further found to be expressed in the HMC-1 the human mast cell precursor line. Furthermore, utilizing the single cell RT-PCR method we detected AChE mRNA expression in Fc epsilon RI-positive single cells derived from human colonic mucosal biopsies. Our findings predict the involvement of mast cell AChE in neuronal-mast cell interactions.
Assuntos
Acetilcolinesterase/metabolismo , Mastócitos/enzimologia , Acetilcolinesterase/genética , Processamento Alternativo , Animais , Sequência de Bases , Comunicação Celular/fisiologia , Linhagem Celular , Colo/citologia , Colo/enzimologia , Primers do DNA/genética , Expressão Gênica , Humanos , Técnicas In Vitro , Mucosa Intestinal/citologia , Mucosa Intestinal/enzimologia , Mastócitos/fisiologia , Camundongos , Dados de Sequência Molecular , Neurônios/fisiologia , Reação em Cadeia da Polimerase , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Distribuição TecidualRESUMO
The exocytosis of beta-hexosaminidase from either IgE-antigen- or calcium ionophore A23187-stimulated murine bone-marrow-derived mast cells was not affected by oxygen-depleted conditions regardless of the absence of glucose from the medium. No detectable changes in the content of ATP were observed when the cells were triggered immunologically under anaerobic conditions in the absence of glucose in the medium. Depletion of oxygen from mast cells activated by both stimuli almost completely inhibited the specific release of arachidonic acid, which indicates that arachidonate does not play a significant role in the secretion of preformed mediators.
Assuntos
Ácidos Araquidônicos/metabolismo , Mastócitos/fisiologia , Trifosfato de Adenosina/metabolismo , Aerobiose , Anaerobiose , Animais , Antígenos , Ácido Araquidônico , Calcimicina/farmacologia , Células Cultivadas , Imunoglobulina E/imunologia , Mastócitos/efeitos dos fármacos , Mastócitos/imunologia , CamundongosRESUMO
This study was undertaken to determine whether zinc, manganese and copper could regulate the thrombin-induced secretion of the granule-associated mediator, beta-hexosaminidase, from mast cells derived from mouse bone marrow. Exposure of thrombin to copper (2-100 microM) does not affect the enzyme-induced release of beta-hexosaminidase from the mast cells. Zinc at 50 microM reduced the degranulation of calcium ionophore A23187 activated cells by 75% and that of immunological challenge or thrombin by 30% each. Exposure of the thrombin to incremental concentrations of manganese (2-100 microM) prevents its degranulation activity in a dose-related fashion. 75% inhibition of the enzyme activity was achieved at 100 microM manganese. However, exposure of IgE sensitized or unsensitized cells to incremental concentrations of manganese (2-400 microM) prior to antigen or calcium ionophore A23187 stimulation, does not significantly affect the exocytosis of beta-hexosaminidase. The binding of purified human FITC-thrombin to E-mast cells was analyzed by fluorescence flow cytometry. All cells bound specifically the labelled thrombin. Pretreatment of the FITC-thrombin with 100 micron zinc or manganese had no effect on the binding of the labelled thrombin to the cells. It was assumed that manganese modulates either directly the thrombin activity or the substrate for the enzyme on the cell surface.
Assuntos
Hexosaminidases/metabolismo , Manganês/farmacologia , Mastócitos/metabolismo , Trombina/metabolismo , Zinco/farmacologia , Animais , Células da Medula Óssea , Calcimicina/farmacologia , Diferenciação Celular , Células Cultivadas , Cobre/farmacologia , Exocitose/efeitos dos fármacos , Citometria de Fluxo , Imunoglobulina E/imunologia , Masculino , Camundongos , Ratos , Taxa Secretória/efeitos dos fármacos , beta-N-Acetil-HexosaminidasesRESUMO
In this work, bovine heparan sulfate, pig mucosa heparin and squid chondroitin sulfate-E glycosaminoglycans (GAGs) were compared as to their affect on the synthesis of leukotrienes C4 (LTC4) and B4 (LTB4) as well as on the production of prostaglandin D2 (PGD2) in cultured mouse E-mast cells (E-MC). The maximum percent increase in LTC4 generation in cells treated with 0.2 micrograms heparan sulfate was 52 +/- 3% (mean +/- S.E., n = 5). Whereas 0.5 micrograms of the GAG increased the production of LTB4 by 50% Ten micrograms of heparin slightly increased the LTC4 production (33%) whereas lower doses were found to be ineffective. No significant increase in LTC4 production was demonstrated when the IgE sensitized E-MC were treated with chondroitin sulfate-E GAG prior to the antigen challenge. Neither one of the three GAGs, at the various doses used, affected the antigen induced exocytosis of beta-hexosaminidase from the IgE sensitized E-MC. After 15 min preincubation with heparan sulfate, antigen induced release of PGD2 from 1 X 10(6) sensitized cells was inhibited from 5.4 ng +/- 0.1 ng into 3.5 ng +/- 0.1 ng at 0.5 micrograms/ml GAG. All of the three types of GAGs used were uneffective when the E-MC were activated by calcium ionophore A23187.
Assuntos
Glicosaminoglicanos/farmacologia , Heparitina Sulfato/farmacologia , Leucotrieno B4/biossíntese , Mastócitos/efeitos dos fármacos , SRS-A/biossíntese , Animais , Calcimicina/farmacologia , Sulfatos de Condroitina/biossíntese , Relação Dose-Resposta a Droga , Glicosaminoglicanos/biossíntese , Heparina/farmacologia , Mastócitos/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Prostaglandina D2 , Prostaglandinas D/biossínteseRESUMO
Thrombin, a highly specific coagulation factor, can rapidly trigger lysozyme release from human neutrophils without concomitant activation of the 5-lipoxygenase pathway. This activation was not dependent on the presence of extracellular calcium. Since thrombin also induces the release of hemostatic and inflammatory metabolites from platelets and mast cells, it is proposed that it plays a significant role in amplification of the inflammatory response.
Assuntos
Neutrófilos/fisiologia , Trombina/fisiologia , Ácido Araquidônico , Ácidos Araquidônicos/sangue , Cálcio/farmacologia , Humanos , Ácidos Hidroxieicosatetraenoicos/sangue , Técnicas In Vitro , Cinética , Muramidase/sangue , Neutrófilos/enzimologiaRESUMO
The role of prostaglandins (PGs) in phagocytosis of sheep erythrocytes (SRC) by mouse spleen adherent cells was examined. A decrease of about 50% in the phagocytosis was observed when macrophages were treated with 5 microgram/ml indomethacin. Concomitant addition of PGs (10(-6) mg/ml), however, prevented the inhibitory effect of indomethacin. It is thus suggested that PGs play an important role in phagocytosis.
Assuntos
Macrófagos/fisiologia , Fagocitose , Prostaglandinas/fisiologia , Animais , Ácidos Araquidônicos/farmacologia , Adesão Celular , Eritrócitos/imunologia , Indometacina/farmacologia , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Ácidos Oleicos/farmacologia , Proteínas Opsonizantes , OvinosAssuntos
Mastócitos/fisiologia , Animais , Divisão Celular/fisiologia , Humanos , Mastócitos/citologiaAssuntos
Ácidos Araquidônicos/metabolismo , Células da Medula Óssea , Mastócitos/metabolismo , Lipídeos de Membrana/metabolismo , Fosfatidilinositóis/metabolismo , Fosfolipídeos/metabolismo , Animais , Araquidonato 5-Lipoxigenase/metabolismo , Calcimicina/farmacologia , Células Cultivadas , Centrifugação com Gradiente de Concentração/métodos , Técnicas de Cultura/métodos , Humanos , Indicadores e Reagentes , Masculino , Mastócitos/citologia , Mastócitos/efeitos dos fármacos , Camundongos , Oxirredução , Técnica de Diluição de Radioisótopos , Trombina/farmacologia , TrítioAssuntos
Macrófagos/imunologia , Prostaglandinas/imunologia , Animais , Sítios de Ligação , Membrana Celular/imunologia , Concanavalina A/farmacologia , Relação Dose-Resposta Imunológica , Fragmentos Fc das Imunoglobulinas/imunologia , Imunoglobulina G/imunologia , Macrófagos/ultraestrutura , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Prostaglandinas/biossínteseRESUMO
Mouse E-mast cells were differentiated and grown by culturing bone marrow cells in medium containing WEHI-3-conditioned medium. These cells possess surface receptors to the following agglutinins: peanut (PNA), concanavalin A (Con A), and soybean (Sb). One to 200 micrograms of PNA/10(6) E-mast cells selectively stimulated the generation of leukotriene C4 (LTC4) in the absence of beta-hexosaminidase release. Exposure of 10(6) E-mast cells to 1 to 200 micrograms Con A or Sb had no effect either on preformed mediator release or on the generation of leukotrienes. LTC4 was quantitated by integrated UV absorbance after resolution by reverse phase high pressure liquid chromatography. The optimum release of LTC4 (13.2 ng/10(6) cells) was achieved by 50 micrograms of PNA/10(6) cells. The response is characterized by the inhibition by excess amounts of PNA. The amount of LTC4 generated during optimal PNA stimulation is lower than the amount produced after stimulation by IgE-antigen or by calcium ionophore A23187 (19.8 ng and 148 ng, respectively). The release of LTC4 began within 5 min after PNA stimulation, and reached a plateau within 45 to 60 min at 37 degrees C. This kinetic pattern is similar to that observed after calcium ionophore A23187 stimulation of these cells. The results suggest that PNA is capable of selectively activating the 5-lipoxygenation of arachidonic acid without affecting beta-hexosaminidase secretion. Apparently, separate biochemical events may serve to mobilize each class of mediators.
Assuntos
Células da Medula Óssea , Lectinas/farmacologia , Lipoxigenase/metabolismo , Mastócitos/enzimologia , Lectinas de Plantas , Proteínas de Soja , Animais , Araquidonato Lipoxigenases , Ativação Enzimática , Lectinas/metabolismo , Masculino , Mastócitos/metabolismo , Camundongos , Camundongos Endogâmicos C3H , Aglutinina de Amendoim , Receptores de Concanavalina A/análise , Receptores Mitogênicos/análise , SRS-A/metabolismoRESUMO
Short-term stimulation (up to 16 hours) of interleukin-3 (IL-3)-dependent mouse bone marrow-derived mast cells, Abelson transformed mouse liver-derived mast cells, or rat basophilic leukemia cells by either IgE-Ag or calcium ionophore A23187 resulted in inhibition of their proliferation as measured by 3H-thymidine incorporation and MTT (tetrazolium) assays, and in accumulation of the mRNAs of c-fos, c-jun, junB and slightly of junD proto-oncogenes. The involvement of protein kinase C (PKC) in these responses was investigated by using several approaches of enzyme activity regulation. Direct activation of the PKC was achieved by short-term exposure of the cells to the PKC-specific activator phorbol 12-myristate-13-acetate (PMA). Inhibition of PKC activity was obtained by either prolonged treatment of the cells with PMA or by exposure of the cells to the PKC inhibitors H-7 and staurosporine. The results showed the following: (1) Short-term exposure of mast cells to PMA was sufficient to induce inhibition of proliferation. (2) An increase in PKC activity was associated with a decrease in the proliferation of IgE-dinitrophenol (DNP) or calcium ionophore A23187-stimulated cells. (3) A direct correlation was found between the increase in PKC activity and the increase in the level of the mRNAs of the jun proto-oncogenes in cells activated by both stimuli mentioned. (4) While an increase in PKC activity was associated with the upregulation of the level of c-fos mRNA during calcium ionophore A23187 stimulation, it showed the opposite effect on the expression of the mRNA of this proto-oncogene when the cells were triggered by IgE-DNP. Therefore, we concluded that PKC plays various roles in the expression of the mRNA of c-fos in activated mast cells depending on the stimulus involved. In addition, the expression of the mRNA of c-jun and junB proto-onogenes is not coordinately regulated with that of c-fos during immunologic stimulation. This discordancy, which is associated with the increase in PKC activity in mast cells, may play a role in the regulation of the transcription of AP-1-responsive genes, and therefore could be associated with the regulation of proliferation of these cells.